Article

Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies.

Cancer Research UK GPRG, Department of Clinical Pharmacology, University of Oxford, Oxford, UK.
Molecular Psychiatry (Impact Factor: 15.15). 09/2005; 10(8):765-70. DOI: 10.1038/sj.mp.4001664
Source: PubMed

ABSTRACT There is strong evidence for a genetic contribution to schizophrenia, but the contribution of individual candidate genes remains uncertain. We attempted to replicate a recent meta-analysis that reported an association of the catechol O-methyltransferase (COMT) Val allele with schizophrenia, and suggested that this effect may be moderated by ancestry. We included reports published subsequent to the original meta-analysis, and included a formal test of the moderating effect of ancestry in order to test whether the association operates differently in populations of European ancestry compared to populations of Asian ancestry. A corrected P-value for the 5% significance threshold was employed where appropriate, using Bonferroni's method, and studies that demonstrated departure from Hardy-Weinberg equilibrium among controls were excluded. When all studies were included in a meta-regression, there was evidence for a significant association of COMT Val allele frequency with schizophrenia case status and a significant main effect of ancestry. The interaction of COMT Val allele frequency and ancestry was also significant. However, when only studies that reported allele frequencies that did not depart significantly from Hardy-Weinberg equilibrium among controls were included, these effects were no longer significant. The results of our meta-analysis do not support an association between the COMT Val allele and schizophrenia case status, and do not support recent claims that this association may be moderated by ancestry.

1 Bookmark
 · 
117 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Men who have sex with men (MSM) are a high risk population for human immunodeficiency virus (HIV) infection. Our study aims to find whether MSM who were recruited online had a higher prevalence of self-reported unprotected anal intercourse (UAI) than those who were recruited offline.
    BMC Public Health 05/2014; 14(1):508. · 2.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cannabis use and childhood maltreatment are independent risk factors for the development of psychotic symptoms. These factors have been found to interact in some but not all studies. One of the reasons may be that childhood maltreatment and cannabis primarily induce psychotic symptoms in genetically susceptible individuals. In this context, an extensively studied psychosis vulnerability gene is catechol-methyl-transferase (COMT). Therefore, we aimed to examine whether the COMT Val(158)Met polymorphism (rs4680) moderates the interaction between childhood maltreatment and cannabis use on psychotic symptoms in the general population. The discovery sample consisted of 918 individuals from a cross-sectional study. For replication we used an independent sample of 339 individuals from the general population. A significant three-way interaction was found between childhood maltreatment, cannabis use, and the COMT genotype (rs4680) in the discovery sample (P=0.006). Val-homozygous individuals displayed increased psychotic experiences after exposure to both cannabis use and childhood maltreatment compared to Met-heterozygous and Met-homozygous individuals. Supportive evidence was found in the replication sample with similar effect and direction even though the results did not reach statistical significance (P=0.25). These findings suggest that a functional polymorphism in the COMT gene may moderate the interaction between childhood maltreatment and cannabis use on psychotic experiences in the general population. In conclusion, the COMT Val(158)Met polymorphism may constitute a genetic risk factor for psychotic symptoms in the context of combined exposure to childhood maltreatment and cannabis use.
    Schizophrenia Research 08/2013; · 4.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mangels Kenntnis der Ätiologie und Pathogenese fehlen für die Schizophrenie kausale Therapieansätze. Seit kurzem sind aber drei postulierte Dispositionsgene für die Schizophrenie zunehmend gut bestätigt: das Dysbindin-Gen, das Neuregulin-1-Gen und das G72/DAOA-Gen. Diese Gene kodieren Proteine von der Hirnentwicklung bis hin zur Aufrechterhaltung der glutamatergen Synapse im reifen Gehirn. Diese Entdeckungen stimulierten die molekulare Ursachen- und Pathogeneseforschung. Neue Erklärungsansätze von neuroanatomischen Befunden deuten auf subtile Hinweise einer gestörten Hirnentwicklung und einen Verlust nichtneuronaler Elemente, des Neuropils, als Korrelat hirnatrophischer Veränderungen hin. Diese Reduktion des Neuropils wird wesentlich durch synaptische Elemente bedingt. Biochemische Befunde zeigen komplementär, dass neben dem dopaminergen sowie serotonergen System insbesondere die glutamaterge Transmission gestört ist. Insgesamt passen diese Befunde gut zu vermuteten Funktionen der Dispositionsgene. Hypothesenfreie Ansätze in der strukturellen Bildgebung sowie die Kombination der funktionellen Bildgebung mit relevanten Genvarianten öffnen neue Wege, um Marker aus der Bildgebung in die Diagnose der Schizophrenie und die Beurteilung der Response auf Neuroleptika mit einzubeziehen. Trotz der Erkenntnisfortschritte, z. B. im Bereich der Genetik, liefern bekannte Risikovarianten derzeit noch keinen Beitrag zur Frühdiagnostik. Darüber hinaus erlaubt die Pharmakogenetik zurzeit keine individuelle Voraussage des Therapieerfolgs bei Antipsychotika.
    Der Nervenarzt 10/2006; 77. · 0.86 Impact Factor

Full-text (2 Sources)

Download
20 Downloads
Available from
Jul 21, 2014